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China’s contribution to primate research is no longer limited to supplying monkeys to 
scientists abroad. With an abundance of wild rhesus macaques, low labor costs, and a 
nonhostile environment for animal research, scientists are finding that China is the place to 
be for research using macaques as models of human disease.China is home to one-tenth of the 
world’s nonhuman primates, with 
about 20 native species and an abun-
dance of rhesus macaques (Macaca 
mulatta). Since India banned exports of 
all primates in 1977, China has steadily 
increased the number of monkeys 
that it exports to about 20,000 annu-
ally today. Although all exported mon-
keys are supposed to have been bred 
and raised in breeding facilities and 
although the government has banned 
the capture of wild monkeys, there has 
been a decline in China’s wild macaque 
population from ?254,000 in 1998 to 
?100,000 in 2003, according to field 
surveys. Alarmed by this trend and cit-
ing a 2002 US National Academy of Sci-
ences report discussing the shortage 
of rhesus monkeys for research (http://
dels.nas.edu/ilar_n/ilarjournal/44_3/
v44n03workshop.pdf), some Chinese 
scientists have urged the government 
to designate the rhesus macaque a 
“national strategic resource” and have 
called for an export ban. Although Chen 
Zhu, vice president of the Chinese 
Academy of Sciences (CAS), does not 
support an export ban, he agrees that 
“we must protect this resource.” Chen 
points out that “conservation efforts 
should involve the protection of habi-
tats in southwest China, which needs 
the support from other ministries and 
local governments.” For its part, CAS 
plans to boost China’s biomedical 
research capabilities and “indigenous 
innovation” (the government’s latest 
buzzword) by capitalizing on the natu-
ral availability of rhesus monkeys.
The Heavyweight Champ
As a first step, CAS injected 10 mil-
lion yuan (about $1.3 million) into 
renovating an old monkey facility at the Kunming Institute of Zoology in 
Yunnan province. The result is the 
Kunming Primate Research Center 
(KPRC), launched in 2005, which is 
China’s largest and arguably best 
primate research facility. The center 
(see Figure 1) now houses 1500 rhe-
sus macaques and several hundred 
monkeys of seven other species, with 
more buildings currently under con-
struction to enable expansion of the 
rhesus population to 2500 within 3 
years. Its new laboratory building has 
3000 square meters of floor space, 
with ultraclean rooms pressurized to 
keep out airborne pathogens; rooms 
for quarantining 360 animals simul-
taneously; and sophisticated instru-
mentation for blood and biochemical 
analysis, pathology, and surgery.
KPRC is seeking accreditation by 
AAALAC (Association for Assess-
ment and Accreditation of Laboratory 
Animal Care) International, a nonprofit 
organization that promotes humane 
treatment of lab animals worldwide 
through its voluntary accreditation 
program. To this end, KPRC has sent 
a veterinarian to the Oregon National 
Primate Research Center (ONPRC) in Cell 129, the United States to learn advanced 
animal care and management tech-
niques. Says Victor Lukas, head of 
the Division of Animal Resources at 
ONPRC, “they are particularly inter-
ested in our computerized database 
for keeping monkey records.”
Meanwhile, KPRC is attracting 
both Chinese and non-Chinese sci-
entists to work there and collabo-
rate. Shoukhrat Mitalipov and Don-
ald Wolf at ONPRC are collaborating 
with KPRC director Ji Weizhi, Zhou Qi 
of CAS’s Institute of Zoology in Bei-
jing, and others to compare different 
somatic cell nuclear transfer (SCNT) 
methods in rhesus macaques. They 
recently reported that one-step 
micromanipulation is superior to 
conventional electrofusion resulting 
in a 13% yield of normal SCNT blas-
tocysts. Zhou is also chief scientist 
of the “nonhuman primate cloning 
and therapeutic cloning project” 
under the Ministry of Science and 
Technology (MOST)’s National Basic 
Research Program. MOST has com-
mitted 9 million yuan for the first 2 
years of this 5-year project. In this 
capacity, Zhou uses KPRC as a base Figure 1. Monkeys of the Middle Kingdom
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to collaborate with local research-
ers and scientists from the French 
National Institute for Agricultural 
Research on cloning related topics, 
such as monkey embryo reprogram-
ming, differentiation of macaque 
stem cells into neural progenitor 
cells, and programmed expression 
of the nonhuman primate genome 
during embryonic development.
Other research at KPRC includes 
comparative primate genomics, led 
by principal investigator Su Bing, 
which received a boost with the pub-
lication this April of the complete 
rhesus macaque genome sequence. 
Su’s group focuses on the genetic 
mechanisms of human evolution by 
comparing gene expression profiles 
in human and nonhuman primate 
brains, in particular the prefrontal 
cortex, to seek out genes that have 
undergone adaptive changes during 
evolution. Su claims to have one of 
the world’s largest rhesus brain tis-
sue collections. He also collaborates 
with other KPRC labs to study mech-
anisms of viral infection, including 
adaptive evolution of the gene encod-
ing TRIM5α, which restricts infection 
of nonhuman primate immune cells 
by HIV-1.
KPRC is also home to an “over-
seas research team,” a group of 
expatriate scientists who collabo-
rate with colleagues back in China 
through a special program funded by 
CAS. The team includes Xiao-Ning 
Xu and Xin Lu, based in Europe, and 
two US-based researchers, You-
Wen He and Yufang Shi. According 
to team leader Xu, the low cost of 
primate research in China is a defi-
nite attraction. “Primate research in 
Europe is very expensive, at least ten 
times more than in China,” explains 
Xu, whose research on HIV and avian 
influenza vaccines needs large num-
bers of animals “to show effect.”
Another team member, Duke Uni-
versity researcher He, is trying to 
establish the tree shrew as an animal 
model for chronic hepatitis B virus 
(HBV) infection. HBV is a serious 
problem in China, with about 10% 
of the population carrying the virus. 
Even though both the chimpanzee 
and tree shrew are susceptible to 1034 Cell 129, June 15, 2007 ©2007 Elseacute HBV infection, there is currently 
no available animal model for chronic 
infection. Twice a year, He travels to 
KPRC to work on tree shrews, which 
are bred at this facility.
Monkey Models of Human 
Disease
In addition to KPRC, there are a 
number of other primate research 
centers in China. Alex Zhang is one 
of the first expatriate Chinese scien-
tists to have seen an opportunity in 
primate research back home. After 
spending 6 years as a research asso-
ciate at Stanford University studying 
neural development in mice, Zhang 
returned to China in 2001 to head 
the Cell Therapy Center at the Bei-
jing Institute of Geriatrics, switching 
his research from rodents to nonhu-
man primates. In 2003, together with 
his longtime collaborator Piu Chan, 
a neurologist also recently returned 
from the United States, he founded 
the company Wincon TheraCells Bio-
technologies, which aims to develop 
cell-based therapies for treating 
neurological and other diseases. The 
partners set up a primate research 
laboratory on land leased from Wei-
mei Biotechnology, a monkey breed-
ing center in Nanning, Guangxi prov-
ince. The center annually breeds 
about 2000 cynomolgus macaques 
(Macaca fascicularis), a close rela-
tive of the rhesus macaque, and 
exports about 1500 of them each 
year. “It’s very convenient; we can 
buy monkeys right outside our door,” 
says Zhang.
With support from the Chinese 
government (10 million yuan over 
5 years) as well as grants from pri-
vate investors and foundations, 
Wincon is developing monkey mod-
els of human diseases, including 
Parkinson’s disease, Alzheimer’s 
disease, and diabetes. In collabo-
ration with the Parkinson’s Institute 
in Sunnyvale, California, Wincon 
researchers will use 115 monkeys 
with drug-induced Parkinson’s dis-
ease for “parallel experiments, let-
ting scientists from different labs 
apply various experimental thera-
peutic methods on the same type of 
disease model so that the outcome vier Inc.can be compared,” says Zhang. Win-
con is also developing a cell-based 
therapy for type I diabetes using a 
monkey model in which pancreatic β 
cells are killed with the drug strep-
tozotocin. Zhang’s group has iso-
lated and characterized pancreatic 
progenitor cells in both healthy and 
diabetic monkeys and plans to treat 
diabetic monkeys with autologous 
transplants of these progenitor cells 
after expansion in culture. Screening 
of large numbers of older monkeys 
that, like humans, spontaneously 
develop type II diabetes as they age 
is also underway, and presymptom-
atic monkeys with elevated blood 
sugar levels have been identified. 
“We are keeping these monkeys as 
we develop a disease model for type 
II diabetes. They may be useful for 
drug testing in the future,” explains 
Zhang. In June of 2006, Wincon 
became the first, and so far the only, 
primate facility in China to receive 
AAALAC accreditation. “Alex’s lab is 
very enabling for translational medi-
cine and very attractive to Western 
scientists,” comments Theo Palmer, 
a neurobiologist at Stanford Univer-
sity, who recently visited Wincon.
Other researchers are also work-
ing with older monkeys as models of 
aging-related diseases in humans. 
For example, scientists at Beijing 
University’s Institute of Molecular 
Medicine (Beida-IMM), founded in 
2005 with 80 million yuan from the 
university, are collaborating with 
Massachusetts General Hospital 
(MGH) in Boston, Massachusetts, 
to study cardiovascular disease. 
“We are screening older rhesus 
macaques for metabolic syndrome 
including diabetes, insulin resis-
tance, obesity, high blood pressure, 
hyperlipidemia, all of which increase 
the risk for cardiovascular disease,” 
explains Paul Huang, director of the 
Cardiac Metabolic Syndrome Pro-
gram at MGH and a leader of the 
collaboration.
Originally, Huang and his col-
leagues considered establishing 
their own rhesus colony near Shen-
zhen in southern China, where the 
climate would allow the monkeys to 
live outside throughout the year. The 
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the idea and was willing to make 
available a self-contained small 
mountain on the city’s outskirts for 
500 to 1000 free-roaming rhesus 
macaques. The colony, dubbed 
“monkey mountain,” would allow 
development of “our own source for 
research. We can follow the mon-
keys over time and do longitudinal 
studies,” says Huang. But the idea 
has been shelved for now because 
taking care of this free-roaming 
monkey colony would divert money 
and manpower away from research 
efforts in Beijing.
Instead, Beida-IMM is spending 
5 million yuan to add a new primate 
wing to the university’s existing animal 
facility. Researchers have screened 
several hundred older rhesus mon-
keys at breeding facilities throughout 
China and have found more than 60 
animals with metabolic syndrome, 
which they are moving to Beijing for 
further study. Beijing University plans 
to obtain AAALAC accreditation for 
its monkey facility and will submit 
their application this summer. “I think 
pharmaceutical companies will feel 
more comfortable with AAALAC-
accredited facilities because that 
means the standard of care is the 
best available,” says Huang, whose 
collaboration with Beida-IMM is 
partly supported by a gift from Roche 
to MGH.
Although most foreign scientists 
collaborate with Chinese colleagues 
to do monkey research, a few have 
struck out on their own. Erwan 
Bezard, an INSERM researcher 
at Université Bordeaux, France, 
started going to China in 1999 while 
a postdoctoral fellow. “European 
labs do not have enough monkeys 
for my work,” he says, noting that he 
needs a large number of animals for 
statistical analysis. Given that China 
is the largest producer of rhesus 
macaques, Bezard moved some of 
his research to Beijing, renting lab 
space first from a monkey breeding 
facility and then from the Institute 
of Laboratory Animal Research at 
the Chinese Academy of Medical 
Sciences (CAMS). Bezard travels 
to China every 6 weeks, spend-ing 6–10 days there each time. He 
supports his monkey experiments 
in China with grants from the Euro-
pean Union and private foundations 
and ships the brains and other tis-
sues back to Europe for postmor-
tem analysis. One project, funded 
by the Michael J. Fox Foundation 
in the United States, involves treat-
ing L-DOPA-induced dyskinesias in 
macaques with Parkinson’s disease 
with a partial agonist of the dopa-
mine D3 receptor.
In addition to his basic research, 
Bezard recently joined forces with a 
British company, Motac Neurosci-
ence, using his Beijing lab and access 
to monkeys for contract research 
with pharmaceutical companies to 
test drugs for treating movement dis-
orders. “We are, I believe, the only 
company in the world to work exclu-
sively with second generation of bred 
animals; they are not inbred, but their 
quality is more controlled and their 
entire history is known,” says Bezard. 
Most of the rhesus macaques and all 
of the cynomolgus monkeys Bezard 
uses come from breeding facilities in 
southern China.
Monkey Welfare
Some outsiders point to the lack of 
laws for laboratory animal use and 
care in China as a potential problem 
for doing primate research there, but 
Chinese researchers counter that 
they voluntarily follow high standards. 
Many of the new generation of primate 
researchers in China have studied in 
the United States or Europe and are 
collaborating with colleagues abroad. 
They understand the importance of 
adopting international standards in 
order for their work to be accepted by 
international peers. They are the ones 
who push the government to estab-
lish regulations concerning animal 
welfare, sometimes at odds with the 
general public.
When the Beijing municipal gov-
ernment released a 2004 draft of 
an animal welfare law on its web-
site for public comment, the reac-
tion was so overwhelmingly nega-
tive that the draft was withdrawn 2 
days later. Many Chinese criticized 
the proposed law for going too far and not being realistic. There are 
135 million Chinese (about one-
tenth of the population) living on 
less than $1 a day, which the World 
Bank defines as abject poverty. In 
comparison, “monkeys listen to 
music, have toys to play with, and 
drink purified water” in Wincon’s 
AAALAC-accredited lab, accord-
ing to Zhang. The 900 million rural 
Chinese who cannot afford basic 
medical care won’t be able to ben-
efit from the millions of yuan spent 
on research to find treatments for 
Parkinson’s disease, diabetes, and 
 cardiovascular disease.
But on the whole, “China is more 
supportive of this kind of work [primate 
research] because improving human 
health comes first,” says Bruce Lahn, 
a geneticist and an HHMI investiga-
tor at the University of Chicago, who 
set up a primate research lab in 2002 
at the Jiufo monkey breeding facility 
in Guangzhou, the city where Lahn’s 
collaborators are based. Lahn set 
ambitious goals for his lab “to gener-
ate transgenic, maybe even knockout 
monkey models for human diseases 
and to use primates both as a source 
and model to study stem cells, 
including embryonic stem cells.” But 
he acknowledges that progress has 
been slow, partly because of insuffi-
cient funding.
Even though the cost of obtaining 
and maintaining monkeys in China 
may be low by Western standards, it 
is still high for Chinese researchers. 
Zhou Zhuan, a biophysicist at Beida-
IMM who is leading the institute’s 
effort for AAALAC accreditation, esti-
mates that to maintain one monkey at 
their facility costs about 25,000 yuan 
per year. “Chinese monkeys are far 
more expensive than we had imag-
ined,” concedes Zhou. He adds that 
when conditions meet international 
standards, the associated costs 
will also approach international lev-
els. Wincon’s Zhang agrees: “From 
our experience of getting AAALAC 
accreditation, we realize that the cost 
of maintaining a monkey at high stan-
dards is not that much less in China 
than elsewhere.”
Another concern is that demand 
for cynomolgus macaques is driving 
smuggling across China’s south-
ern border. Cynomolgus monkeys 
are not native to China, but come 
from southern Indochina. They can 
be bought cheaply in Vietnam, for 
instance, and then can be sold in 
China for ten times their purchase 
price. The number of monkeys 
being smuggled into China is diffi-
cult to track, but customs officials 1036 Cell 129, June 15, 2007 ©2007 Elsin Guangxi busted two smuggling 
operations last summer, resulting 
in the arrest of nine people and the 
rescue of 197 live cynomolgus mon-
keys at the Vietnamese-Chinese 
border.
“Biomedical research in nonhuman 
primates is still new in China,” says 
CAS vice president Chen. “We need 
international collaboration in many evier Inc.aspects, not the least in borrowing 
from international standards for ethi-
cal treatment of lab animals.” Chen 
emphasizes that CAS is formulating 
rules for using animals in research as 
part of the ambitious plan of build-
ing a network of primate research 
groups across China using KPRC as 
the platform for sharing this precious 
resource.
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